Phase 1 Start~month

Phase 1 Start: An Open-Label, Four-Treatment, Parallel Study of the Comparative Pharmacokinetics of a Progesterone

Other upcoming events for DARE

Patent ExpiryPatent/Exclusivity Expiry: XACIATO

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 1 Start: An Open-Label, Four-Treatment, Parallel Study of the Comparative Pharmacokinetics of a Progesterone — DARE Phase 1 Start | BioSniper